Monument Economics Group, a leading provider of economic consulting services and expert testimony, is pleased to announce that Dr. Philip Cross has partnered with the firm as an Affiliate. Read Full Article
Read More
News & Events
News & Events
Monument Economics Group Celebrates Local Charities this Holiday Season
Monument Economics Group has again made donations to local charities on behalf of its business partners: So Others Might Eat and DC Scores in Washington, DC; Robin Hood Foundation in New York, NY; Broad Street Ministry in Philadelphia, PA; Greater Chicago Food Depository in Chicago, IL; and Semper Fi Fund in San Diego, CA. All […]
Read More
Allergan PLC Agrees To Pay $750 Million To Settle Namenda Antitrust Suit
In 2015, Plaintiffs filed a First Amended Class Action Complaint on behalf of a proposed class of direct purchasers of branded and generic Namenda, a drug used to treat moderate-to-severe Alzheimer’s, alleging a two-pronged scheme on the part of Defendants to impair generic competition, including a “reverse payment” agreement to delay generic entry, and the […]
Read More
Judge Cites Dr. Lamb’s Analysis in Certifying Class of Indirect Purchasers of Branded or Generic Lovenox
In 2017, Plaintiffs filed an Amended Complaint on behalf of a proposed class of indirect purchasers of Lovenox, and/or its generic equivalent enoxaparin, alleging an agreement among Defendants to monopolize sales of enoxaparin and prevent competition by controlling patented technology used to establish sameness for purposes of obtaining FDA approval to market generic enoxaparin. Counsel […]
Read More
Court Finds for Department of Labor in Key Employee Stock Ownership Plan Dispute
In 2016, the Department of Labor (DOL) challenged a 2010 acquisition of the remaining 52% of shares of Sentry Equipment Erectors Inc. by its Employee Stock Ownership Plan (ESOP), claiming it overpaid in its $21 million purchase of the shares from company owner Adam Vinoskey, who was also an ESOP Trustee.
Read More